227 related articles for article (PubMed ID: 31797180)
1. Aberrantly expressed microRNAs and their implications in childhood central nervous system tumors.
Pezuk JA; Salomão KB; Baroni M; Pereira CA; Geron L; Brassesco MS
Cancer Metastasis Rev; 2019 Dec; 38(4):813-828. PubMed ID: 31797180
[TBL] [Abstract][Full Text] [Related]
2. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
[TBL] [Abstract][Full Text] [Related]
3. Survey of MicroRNA expression in pediatric brain tumors.
Birks DK; Barton VN; Donson AM; Handler MH; Vibhakar R; Foreman NK
Pediatr Blood Cancer; 2011 Feb; 56(2):211-6. PubMed ID: 21157891
[TBL] [Abstract][Full Text] [Related]
4. Advances in the biology and treatment of pediatric central nervous system tumors.
Vitanza NA; Cho YJ
Curr Opin Pediatr; 2016 Feb; 28(1):34-9. PubMed ID: 26709691
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of pediatric central nervous system tumors.
Ullrich NJ; Pomeroy SL
Curr Oncol Rep; 2006 Nov; 8(6):423-9. PubMed ID: 17040620
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
[TBL] [Abstract][Full Text] [Related]
7. The role of stem cells in pediatric central nervous system malignancies.
Manoranjan B; Garg N; Bakhshinyan D; Singh SK
Adv Exp Med Biol; 2015; 853():49-68. PubMed ID: 25895707
[TBL] [Abstract][Full Text] [Related]
8. Noncoding RNAs in pediatric brain tumors: Molecular functions and pathological implications.
Chen S; Deng X; Sheng H; Rong Y; Zheng Y; Zhang Y; Lin J
Mol Ther Nucleic Acids; 2021 Dec; 26():417-431. PubMed ID: 34552822
[TBL] [Abstract][Full Text] [Related]
9. Genetics of pediatric central nervous system tumors.
Biegel JA
J Pediatr Hematol Oncol; 1997; 19(6):492-501. PubMed ID: 9407934
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnostics in central nervous system tumors.
Fuller CE; Perry A
Adv Anat Pathol; 2005 Jul; 12(4):180-94. PubMed ID: 16096380
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of pediatric brain tumors.
Biegel JA; Pollack IF
Curr Oncol Rep; 2004 Nov; 6(6):445-52. PubMed ID: 15485613
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA based theranostics for brain cancer: basic principles.
Petrescu GED; Sabo AA; Torsin LI; Calin GA; Dragomir MP
J Exp Clin Cancer Res; 2019 May; 38(1):231. PubMed ID: 31142339
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Int J Mol Sci; 2014 Nov; 15(11):21554-86. PubMed ID: 25421247
[TBL] [Abstract][Full Text] [Related]
14. PARP1 expression in pediatric central nervous system tumors.
Barton VN; Donson AM; Kleinschmidt-DeMasters BK; Gore L; Liu AK; Foreman NK
Pediatr Blood Cancer; 2009 Dec; 53(7):1227-30. PubMed ID: 19533660
[TBL] [Abstract][Full Text] [Related]
15. Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers.
Arakaki AKS; Szulzewsky F; Gilbert MR; Gujral TS; Holland EC
Neuro Oncol; 2021 Nov; 23(23 Suppl 5):S4-S15. PubMed ID: 34725698
[TBL] [Abstract][Full Text] [Related]
16. Rare Primary Central Nervous System Tumors Encountered in Pediatrics.
Kramer K
J Child Neurol; 2016 Oct; 31(12):1394-8. PubMed ID: 26801774
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown.
Braoudaki M; Lambrou GI
J Hematol Oncol; 2015 Feb; 8():6. PubMed ID: 25652781
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic analysis of 109 pediatric central nervous system tumors.
Neumann E; Kalousek DK; Norman MG; Steinbok P; Cochrane DD; Goddard K
Cancer Genet Cytogenet; 1993 Nov; 71(1):40-9. PubMed ID: 8275451
[TBL] [Abstract][Full Text] [Related]
19. Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors.
Robinson GW; Witt H; Resnick A
Am Soc Clin Oncol Educ Book; 2016; 35():e540-6. PubMed ID: 27249765
[TBL] [Abstract][Full Text] [Related]
20. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
Grundy RG; Wilne SH; Robinson KJ; Ironside JW; Cox T; Chong WK; Michalski A; Campbell RH; Bailey CC; Thorp N; Pizer B; Punt J; Walker DA; Ellison DW; Machin D;
Eur J Cancer; 2010 Jan; 46(1):120-33. PubMed ID: 19818598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
